Logo image of EXA.PA

EXAIL TECHNOLOGIES (EXA.PA) Stock Fundamental Analysis

EPA:EXA - Euronext Paris - Matif - FR0000062671 - Common Stock - Currency: EUR

88.1  +2.2 (+2.56%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EXA. EXA was compared to 108 industry peers in the Machinery industry. EXA has a bad profitability rating. Also its financial health evaluation is rather negative. EXA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EXA had negative earnings in the past year.
EXA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXA reported negative net income in multiple years.
Of the past 5 years EXA 4 years had a positive operating cash flow.
EXA.PA Yearly Net Income VS EBIT VS OCF VS FCFEXA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

EXA's Return On Assets of -0.44% is on the low side compared to the rest of the industry. EXA is outperformed by 75.00% of its industry peers.
EXA's Return On Equity of -3.04% is on the low side compared to the rest of the industry. EXA is outperformed by 75.00% of its industry peers.
With a Return On Invested Capital value of 2.85%, EXA is not doing good in the industry: 69.44% of the companies in the same industry are doing better.
EXA had an Average Return On Invested Capital over the past 3 years of 2.19%. This is significantly below the industry average of 9.09%.
The last Return On Invested Capital (2.85%) for EXA is above the 3 year average (2.19%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROIC 2.85%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
EXA.PA Yearly ROA, ROE, ROICEXA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

Looking at the Operating Margin, with a value of 6.05%, EXA is in line with its industry, outperforming 47.22% of the companies in the same industry.
In the last couple of years the Operating Margin of EXA has grown nicely.
Looking at the Gross Margin, with a value of 55.36%, EXA is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
EXA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.05%
PM (TTM) N/A
GM 55.36%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
EXA.PA Yearly Profit, Operating, Gross MarginsEXA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXA is destroying value.
EXA has less shares outstanding than it did 1 year ago.
EXA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EXA has a worse debt to assets ratio.
EXA.PA Yearly Shares OutstandingEXA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EXA.PA Yearly Total Debt VS Total AssetsEXA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.05 indicates that EXA is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXA has a Altman-Z score of 2.05. This is comparable to the rest of the industry: EXA outperforms 49.07% of its industry peers.
The Debt to FCF ratio of EXA is 6.15, which is on the high side as it means it would take EXA, 6.15 years of fcf income to pay off all of its debts.
EXA has a Debt to FCF ratio of 6.15. This is comparable to the rest of the industry: EXA outperforms 49.07% of its industry peers.
EXA has a Debt/Equity ratio of 2.52. This is a high value indicating a heavy dependency on external financing.
EXA's Debt to Equity ratio of 2.52 is on the low side compared to the rest of the industry. EXA is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Altman-Z 2.05
ROIC/WACC0.4
WACC7.05%
EXA.PA Yearly LT Debt VS Equity VS FCFEXA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

EXA has a Current Ratio of 1.25. This is a normal value and indicates that EXA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, EXA is not doing good in the industry: 71.30% of the companies in the same industry are doing better.
A Quick Ratio of 0.93 indicates that EXA may have some problems paying its short term obligations.
With a Quick ratio value of 0.93, EXA perfoms like the industry average, outperforming 42.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.93
EXA.PA Yearly Current Assets VS Current LiabilitesEXA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for EXA have decreased strongly by -128.05% in the last year.
EXA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.32%.
Measured over the past years, EXA shows a small growth in Revenue. The Revenue has been growing by 6.32% on average per year.
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%

3.2 Future

The Earnings Per Share is expected to grow by 88.61% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.49% on average over the next years. This is quite good.
EPS Next Y1276.91%
EPS Next 2Y447.16%
EPS Next 3Y235.58%
EPS Next 5Y88.61%
Revenue Next Year20.26%
Revenue Next 2Y22.47%
Revenue Next 3Y19.45%
Revenue Next 5Y14.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXA.PA Yearly Revenue VS EstimatesEXA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
EXA.PA Yearly EPS VS EstimatesEXA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXA. In the last year negative earnings were reported.
EXA is valuated quite expensively with a Price/Forward Earnings ratio of 100.03.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXA indicates a slightly more expensive valuation: EXA is more expensive than 76.85% of the companies listed in the same industry.
EXA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 100.03
EXA.PA Price Earnings VS Forward Price EarningsEXA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200 -300 -400

4.2 Price Multiples

EXA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.07
EV/EBITDA N/A
EXA.PA Per share dataEXA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

EXA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXA's earnings are expected to grow with 235.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y447.16%
EPS Next 3Y235.58%

0

5. Dividend

5.1 Amount

No dividends for EXA!.
Industry RankSector Rank
Dividend Yield N/A

EXAIL TECHNOLOGIES

EPA:EXA (6/20/2025, 7:00:00 PM)

88.1

+2.2 (+2.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)07-23 2025-07-23
Inst Owners20.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.53B
Analysts84.44
Price Target53.88 (-38.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-41.67%
DP-10.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)76.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 100.03
P/S 4.11
P/FCF 27.07
P/OCF 16.79
P/B 12.8
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)0.88
Fwd EY1%
FCF(TTM)3.25
FCFY3.69%
OCF(TTM)5.25
OCFY5.96%
SpS21.42
BVpS6.88
TBVpS-17.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROCE 3.88%
ROIC 2.85%
ROICexc 3.14%
ROICexgc 14.88%
OM 6.05%
PM (TTM) N/A
GM 55.36%
FCFM 15.2%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
ROICexc(3y)2.4%
ROICexc(5y)3.68%
ROICexgc(3y)9.45%
ROICexgc(5y)12.41%
ROCE(3y)2.98%
ROCE(5y)3.95%
ROICexcg growth 3Y18.91%
ROICexcg growth 5Y18.06%
ROICexc growth 3Y-17.84%
ROICexc growth 5Y1.29%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 9.3%
Interest Coverage 1.55
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.93
Altman-Z 2.05
F-Score5
WACC7.05%
ROIC/WACC0.4
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.56%
Cap/Sales(5y)12.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
EPS Next Y1276.91%
EPS Next 2Y447.16%
EPS Next 3Y235.58%
EPS Next 5Y88.61%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%
Revenue Next Year20.26%
Revenue Next 2Y22.47%
Revenue Next 3Y19.45%
Revenue Next 5Y14.49%
EBIT growth 1Y1338.9%
EBIT growth 3Y22.08%
EBIT growth 5Y23.35%
EBIT Next Year179.27%
EBIT Next 3Y66.38%
EBIT Next 5Y37.94%
FCF growth 1Y137.85%
FCF growth 3YN/A
FCF growth 5Y40.49%
OCF growth 1Y64.25%
OCF growth 3YN/A
OCF growth 5Y26.69%